Zimbabwe has rejected a substantial US healthcare agreement valued at 367 million US dollars (272 million pounds) spanning five years due to the United States' demand for confidential information.
The decision was revealed after a official document dated December was disclosed, indicating that Head of State Emmerson Mnangagwa felt the arrangement was "skewed".
An official spokesman has since stated that the United States was demanding access to genetic material for scientific study and commercial gain while refused to guarantee the resulting advantages from any future medical innovations.
"We will now turn to the challenging and unfortunate task of ending our health aid in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the US had provided over $1.9bn for health programmes to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has called for more dialogue to secure a deal acceptable to all parties so the nation's vital HIV programme can proceed.
Wider Context
This development comes after a similar case in Kenya, where a court suspended a similar deal with the US following concerns were raised about the safety of citizens' health data.
After returning to office recently, US President Donald Trump has slashed foreign aid and shut down the key foreign aid agency.
The agency had overseen aid for the US government, but Trump claimed its spending was "wasteful" and his government was pursuing government-to-government deals to enhance openness and accountability.
According to statements, Sixteen nations in Africa have to date signed similar health pacts, representing over $18.3bn of fresh investment.
Details of the Rejected Agreement
The funds for Zimbabwe would have gone towards "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this collaboration would have delivered extraordinary benefits for Zimbabwean communities, especially the 1.2 million presently receiving antiretroviral therapy through American-funded initiatives," the Ambassador commented.
However, official spokesman Nick Mangwana said the arrangement was "unequal".
"Zimbabwe was being asked to surrender its biological resources and data indefinitely, without any equivalent guarantee of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could result from that provided information," he stated.
"Put simply, our country would provide the raw materials for medical research without any assurance that the final treatments would be available to our citizens should a new health crisis arise."
Sovereignty and International Frameworks
He also said that the American exit from the World Health Organization (WHO) and its push of bilateral health agreements were disrupting systems previously set up through the global organization.
The spokesperson gave as an example its Pandemic Benefit-Sharing scheme created to deal with future pandemics.
"This framework is intended to ensure that when a country provides its samples, the benefits – such as medicines and cures – are shared equitably, not commercialised exclusively by those with the funds to develop them."
Zimbabwe's reservations over the US deal "are not meant as opposition to America," he added.
"We encourage ongoing discussions with our American counterparts on how subsequent collaboration might be structured in a manner that respects the independence and interests of each country."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it recognised the government's concerns, but recommended that negotiations must proceed considering much of the country's HIV programmes depended on external financing.
"In cases where technical issues exist, such as those relating to information security or agreement terms, these can often be addressed through technical clarification and negotiated safeguards," it added.
This impasse emphasises the ongoing debate between receiving crucial foreign assistance and safeguarding a country's data in an increasingly interconnected world.